drugset / Trial / NCT04205929
Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant Users
RandomizedParallel-groupTriple-blindTreatment
Summary
The investigators plan to study the effects of curcumin, the active ingredient in the spice turmeric, on the irregular bleeding experienced by women who use the contraceptive implant.
Timeline
- Start
- 2020-04-15
- Primary completion
- 2022-11-05
- Completion
- 2023-08-01
Outcome
Missed primary endpoint
paper Daily use of curcumin did not improve bleeding patterns in users of the etonogestrel contraceptive implant experiencing frequent or prolonged bleeding patterns. PMID 37116825 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Curcumin | Small molecule | 600 mg | Oral |